• HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorials
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your Course or Conference
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR Funded?
    • Editorial Board
    • Peer Reviewers
    • ACNR Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Journal Signup
    • ACNR Privacy Policy
This website is intended for healthcare professionals
ACNR
  • HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
      • Articles
      • History
      • Letters to the Editor
      • Reviews
      • Personal Perspectives
      • View All
    • Book Reviews
    • Case Reports
    • News
    • Project Neurology Webinar Series
    • Sponsored Editorials
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your Course or Conference
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR Funded?
    • Editorial Board
    • Peer Reviewers
    • ACNR Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • ACNR Online Community Signup
    • ACNR Privacy Policy
  • Menu

ACNR ARTICLES

An integrated management algorithm for post-stroke hemiplegic shoulder pain

Publication Date: 29 Jan 2026

Article written by:
Rajinder Singh, Maddy Kenny, Manoj Sivan

Authors

  • Rajinder Singh
  • MB, ChB (Hons), MRes, FEBPRM, DipMSKMed, EDPM
  • Leeds Teaching Hospitals NHS Trust, UK

Rajinder Singh, MB, ChB (Hons), MRes, FEBPRM, DipMSKMed, EDPM, is a Rehabilitation Medicine Consultant at Leeds Teaching Hospitals NHS Trust and a Honorary Senior Lecturer at the University of Leeds, UK. His interests include Stroke Rehabilitation, Pain Medicine and Musculoskeletal Medicine.

  • Maddy Kenny
  • Leeds Teaching Hospitals NHS Trust, UK

Maddy Kenny is a Clinical Specialist Physiotherapist in complex neurorehabilitation with research interests in stroke rehabilitation and the translation of evidence into clinical practice. She recently completed an NIHR Clinical Doctoral Research Fellowship using a realist-informed approach to supporting self-directed upper limb exercise after stroke.

  • Manoj Sivan
  • FRCP Edin, MD,
  • Leeds Teaching Hospitals NHS Trust, UK

Manoj Sivan, FRCP Edin, MD, is a Professor and Honorary Consultant in Rehabilitation Medicine at the University of Leeds and Leeds Teaching Hospitals and Community Healthcare NHS trusts. He is also an Honorary Senior Lecturer in the Human Pain Research Group at the University of Manchester, UK. His research interests are pain medicine, autonomic medicine, rehabilitation technology, chronic conditions and outcome measurement.

Correspondence Email:
rajinder.singh10@nhs.net

Conflict of Interest Statement:
None declared

Provenance and Peer Review:
Submitted and externally reviewed

Publication Dates:

Date First Submitted:
03 Jun 2025

Date Submitted after Peer Review:
12 Jan 2026

Acceptance Date:
13 Jan 2026

Publication Date:
29 Jan 2026

To Cite:
Singh R, Kenny M, Sivan M. "An integrated management algorithm for post-stroke hemiplegic shoulder pain." Adv Clin Neurosci Rehabil 2026;
https://doi.org/10.47795/ARDY7551

Licence:
Creative Commons Attribution

Acknowledgements

The authors would like to thank all the healthcare professionals and patients of the working group who contributed to the development of this algorithm.


Article Categories

  • ABN (13)
  • ABNT (20)
  • Alzheimer's Disease (8)
  • Aquired Brain Injury (21)
  • Australia/NewZealand (34)
  • Clinical Review (180)
  • Communication aids (1)
  • COVID-19 (16)
  • Dementia (18)
  • Epilepsy (31)
  • Headache (19)
  • History (53)
  • Huntington's Disease (3)
  • Movement Disorders (20)
  • Multiple Sclerosis (25)
  • Myasthenia Gravis (7)
  • Neurological Literature (15)
  • Neurological Signs (10)
  • Neuroopthalmology (5)
  • Neuropsychiatry (7)
  • Neurosurgery (41)
  • Nutrition (5)
  • Paediatric neurology (15)
  • Pain (9)
  • Parkinson's Disease (43)
  • Personal Perspectives (19)
  • Regeneration (3)
  • Rehabilitation (57)
  • Sleep (18)
  • Special Feature (52)
  • Stroke (28)

Abstract

Hemiplegic shoulder pain is a common complication after stroke which results in considerable morbidity.  The management of this condition varies between clinicians in different rehabilitation settings.  The authors propose a structured approach to manage hemiplegic shoulder pain that takes into account time since stroke, type of pain, spasticity, range of movement, muscle power and individual clinical presentation.  Consensus multidisciplinary (physicians, therapists, nurses and patients) agreement was used to develop a step-wise approach to the assessment and management of hemiplegic shoulder pain.  The management algorithm includes non-pharmacological and pharmacological treatment options for focal and neuropathic pain syndromes in acute, sub-acute and chronic phases after stroke.  This pragmatic and multidisciplinary clinical management algorithm is likely to improve the quality of care provided to these patients and also potentially improve outcomes.


Introduction

Hemiplegic shoulder pain (HSP), also known as post-stroke shoulder pain, has a prevalence of up to 47% and represents one of the commonest problems in the post-stroke period [1]. Whilst the onset has been reported as early as 2 weeks after stroke, the typical presentation is 2 to 3 months later [2].  HSP has been demonstrated to worsen functional outcomes, limit participation in rehabilitation and reduce quality of life [3].  HSP is multifactorial but can be split into two broad aetiological categories; focal (shoulder subluxation, rotator cuff abnormalities, bicep tendonitis, soft tissue trauma, brachial plexus traction neuropathies, adhesive capsulitis and spasticity of the shoulder muscles) and central (complex regional pain syndrome and central post-stroke pain). Whilst HSP is relatively common, there can be a varied approach to management depending on the skill set and availability of interdisciplinary input and support.  Structured management algorithms can be useful in addressing this by standardising care across settings.

Objectives and development of the algorithm

The objectives of developing a HSP management algorithm were to a) guide healthcare professionals in the assessment of HSP and b) provide a comprehensive management strategy that takes into account the various variables such as timing of stroke, available range of movement, residual power and spasticity of involved muscles. This algorithm builds upon existing literature on this topic, but adds a more practical, clinical dimension as well as introducing newer injectable interventions [4].

Development of the algorithm followed a pragmatic, consensus-informed approach.  An initial narrative review of the literature was undertaken using MEDLINE, PubMed, Web of Science and PsycINFO databases.  Search terms included combinations of “hemiplegic shoulder pain”, “post-stroke shoulder pain”, “stroke rehabilitation”, “spasticity”, “suprascapular nerve block”, “botulinum toxin”, and “functional electrical stimulation”. English-language studies involving adult stroke populations were included.  Systematic reviews, meta-analyses and randomised controlled trials were prioritised where available, with observational studies and expert reviews used where higher-level evidence was lacking.

Based on the retrieved evidence, a provisional algorithm was drafted by the authors.  This was reviewed by a multidisciplinary working group consisting of rehabilitation physicians, physiotherapists, occupational therapists, nursing staff, and patient representatives. Participants were selected based on clinical experience in stroke rehabilitation and shoulder pain management.  Feedback was provided iteratively over three rounds of review, with revisions made after each round until consensus agreement was achieved.  A formal Delphi process was not used; however, consensus was reached through structured discussion and agreement within the group.

Preventative measures

During development of this algorithm, literature was reviewed to establish best practice regarding preventative strategies in the context of HSP.

Preventative measures should be standard practice in clinical environments caring for people with stroke.  Individuals particularly at risk of HSP include patients with advancing age, female gender, haemorrhagic stroke, poor National Institutes of Health Stroke Scale score, hemispatial neglect, left-sided hemiparesis, increased tone and sensory impairment [1].   It is important for clinicians to have an awareness of these risk factors in order to manage these groups appropriately. 

Whilst there is a lack of high quality evidence regarding preventative strategies for HSP, careful handling and therapeutic positioning of the patient’s upper limb during the early (or flaccid) stage may minimise the degree of pain and subsequent injury [5].  Educational awareness is important for patients and their carers; structured educational initiatives may empower these groups to position and handle the limb appropriately in order to protect it [6].

Clinical assessment

A thorough clinical history and examination is essential when assessing patients with suspected HSP in order to deduce the cause of pain.  Pain can be central or focal, with overlap between both presentations sometimes occurring.  Timing of assessment is particularly important as clinical presentation tends to differ throughout the clinical course.  The algorithm presented in this paper reflects this.

Central post-stroke pain (CPSP) is often described by patients as lacerating, aching, burning, freezing or squeezing.  Spontaneous dysthaesia, abnormal sensitivity to pinprick and high temperatures may also be reported.  On examination there may be allodynia, altered perception of touch and two-point discrimination [7].  Complex regional pain syndrome (CRPS) is characterised by consistent pain of a severe nature associated with changes in sensory, vasomotor, oedema/sudomotor, and motor/trophic domains [8].  Examination may elicit signs consistent with these features.

While focal causes of HSP may present in a varied manner depending on the aetiology involved, commonly patients will complain of a localised, dull, aching pain which is worse with movement and relieved in certain positions.  A detailed examination is critical in establishing the underlying issue.  It is worth noting that a thorough examination may detect pathology in the shoulder more than self-reported symptoms may indicate [9].

With both central and focal causes of HSP it is important to keep patients under review in order to assess their progress.  This is due to the potential for the development of reduction in range of movement which may be accompanied by increased tone after the first two weeks.

| Sign up to the ACNR email newsletter here |

The algorithm

The algorithm presented is divided into three sections depending on the natural time course of the patient’s presentation; acute, subacute and chronic.  Structuring the algorithm in this way ensures that professionals can easily and rapidly utilise the guidance within depending on the clinical timescales involved for each patient.  We briefly present the salient points of each presentation here before going on to provide further evidence-based detail on recommended interventions thereafter.

Acute HSP

Commonly HSP presents within two weeks of the stroke event and medical instability necessitates a rapid approach to pain management.  An initial assessment should determine whether the patient’s pain is central or focal (or both).  Analgesia in conjunction with physical therapy and targeted treatment with a suprascapular nerve block is commonly used in clinical practise  in the early stages (Figure 1a).  While randomised controlled trial data support short-term pain reduction with suprascapular nerve blocks, evidence regarding long-term functional benefit remains limited [10, 11].

There are several practical advantages of a suprascapular nerve block.  Firstly the procedure can be performed at the bedside without the need for formal image guidance. As well as having a quick analgesic onset of action, safety has been demonstrated in the literature [10,11]. Early adoption of a targeted intervention such as a suprascapular nerve block means potential less reliance upon medium to long-term pharmacotherapy for pain control. Any gains made in pain control during this early phase will help to optimise the patient for the ongoing rehabilitation process following stroke and may reduce the risk of subsequent complications.  This recommendation is based on a combination of available evidence and expert clinical consensus rather than definitive long-term outcome data.

Subacute HSP

After 2 weeks spasticity and reduced range of movement are the additional aspects to consider and management should be tailored to include treatment of these issues (Figure 1b). Whilst the onset of spasticity can vary between patients, it will often feature between 1 to 3 months post-stroke.  Permanent impairment of joint movement has been known to occur 3 to 6 weeks post-stroke and highlights the need to manage spasticity promptly and effectively [12].

A suprascapular nerve block remains very useful to consider in these patients for similar reasons as in the acute phase.  Additionally pain aggravates spasticity and therefore early definitive treatment of pain will reduce the impact of spasticity and may negate the need for subsequent pharmacological management.

Whilst focal musculoskeletal pain can have broad causative factors, it ultimately stems from impaired biomechanics within the glenohumeral joint which presents as decreased range of movement.  This is known to mainly occur within the subacute and chronic phases following a stroke [13].  In such patients intra-articular steroid injections or hydrodistension may be helpful to reduce pain and increase function.  Evidence for these interventions in post-stroke populations is moderate, and benefits appear greatest in carefully selected patients with clinical features consistent with adhesive capsulitis.

Chronic HSP

Whilst the neural aspects of spasticity are most apparent at roughly 3 months post-stroke, the muscular component of spasticity can worsen with time beyond this period [12]. As a result spasticity may be a more significant problem in the chronic phase (Figure 1c). While suprascapular nerve blocks can be used to target the precipitating factors of hypertonicity-related pain, oral or injectable pharmacological treatments are often required at this stage.

Central stroke pain is known to be a delayed complication after stroke as a result of changes occurring in the somatosensory pain pathways [14]. As a result, the presence of central sensitisation means that neuropathic analgesics often play a role (as opposed to conventional opiate based medication and basic analgesia).

Therapy interventions

As with the pharmacological treatment of HSP, therapy interventions are guided by assessment to identify the often multi-factorial precipitating factors.

Whether focal, central, or a combination of the two,  once established, a ‘vicious cycle of pain, limited range of movement, reinjury and somatic sensitisation’ may ensue [15]. Therapy interventions may break into this cycle by restoring range of movement, appropriate patterns of motor control, prevention of ongoing trauma, and direct pain control.

Interventions can be broadly categorised into those that protect the soft tissues from repeated damage, and those which work to restore function whilst promoting a more appropriate movement pattern.

Positioning and support

Education to promote careful handling and positioning is important in both the prevention and ongoing management of HSP [16].

Positioning is the most commonly used therapy intervention to address HSP [16]. It is considered good practice to ensure when seated or lying the arm is always supported, with an element of protraction at the shoulder, and avoidance of internal rotation and adduction. Whilst this may be a broad guide, a range of positions will be required to prevent stiffness and promote comfort [16].

This is only an option when resting, and for support to be provided when moving, shoulder supports can be used. There is limited evidence that these may reduce pain, are well tolerated and those that have a humeral and forearm support have the advantage of allowing elbow flexion/extension and a more natural alignment by the body during stance [17].

Shoulder strapping or taping is sometimes used with an aim of providing increased sensory feedback, reducing subluxation and promoting normal alignment [18,19] with some evidence that this can result in reduced pain and shoulder subluxation [19]. Strapping and shoulder supports may also provide a visible marker of a hemiplegic shoulder, thus acting as a prompt for the patient and carer to be mindful of careful handling.

Exercise and Movement

HSP has been associated with a loss of pain free passive range of movement and a lack of motor control although a causal link has not been established [20, 21]. Maintenance of range of movement is important, with care to ensure when flexing and abducting the shoulder above 90 degrees that it is accompanied by external rotation of the humerus and upward rotation of the scapula [22]. Limitations in range of movement need to be assessed and addressed on an individual basis.

Active exercises maintaining the usual movement patterns to drive recovery of appropriate motor control are also indicated, as are those that promote postural control of the pelvis and trunk [22].

Functional Electrical Stimulation (FES) aims to stimulate the muscles around the shoulder to produce a muscle contraction, mainly with a view to reducing subluxation. There is evidence that early use of FES can reduce subluxation during the treatment period,  however current evidence does not consistently demonstrate sustained reductions in pain or long-term functional improvement [23]. Its use is therefore best considered as an adjunctive therapy, particularly in the early post-stroke phase, rather than a definitive pain management intervention.

Medical interventions

Pharmacological treatment

Simple analgesia can be effective for HSP with a focal nociceptive cause. The WHO pain ladder [24] offers a structured approach to pain management which can be adopted for these patients, including paracetamol, non-steroidal anti-inflammatory medication and opiates if no contraindications exist to these medications. Careful review is required after the introduction of any analgesics before further changes are made.

Central causes of HSP may respond to neuropathic analgesia. Anti-convulsants such as Pregabalin and Gabapentin have some evidence of effect in the context of central post-stroke pain and can be considered first-line [25,26].  Whilst strong evidence is lacking for their use in HSP these drugs are widely available and have a robust evidence base in other types of neuropathic pain syndromes. After gradual up titration of one of these medications to the maximum tolerated dose, a pain assessment should be undertaken to establish whether satisfactory pain reduction has been achieved before an alternative neuropathic agent is introduced. A tricyclic antidepressant such as Amitriptyline can be used in combination with Pregabalin or Gabapentin if pain does not improve but can also be used in isolation if side- effects manifest with anticonvulsant therapy [27].

In the event of sustained improvement, analgesia should be gradually reduced whilst keeping symptoms under review.

Targeted treatment

Targeted therapies such as nerve blocks, intramuscular and intra-articular injections and hydrodistension are recommended for HSP with a focal component.

A suprascapular nerve block can be useful in these patients due to its targeted effect on the suprascapular nerve which innervates sensory fibres to the majority of the shoulder joint, capsule and acromioclavicular joint. The evidence predominantly advocates the use of long acting local anaesthetic in combination with corticosteroid. Suprascapular nerve block has demonstrated short-term benefit in passive range of movement of the shoulder joint in addition to providing significant pain reduction, although data on sustained functional gains remain limited [10].

Spasticity is a common complication of stroke and is a well-known contributor to HSP. Oral medication such as Baclofen, Tizanadine, Dantrolene and Benzodiazepines play a part in managing spasticity but may have a stronger role if the symptoms are multifocal, regional or generalised [28]. Their use is limited by their side effect profile. Symptoms of HSP related focal muscle spasticity respond well to targeted botulinum neurotoxin type A injection. Injection into the subscapularis or pectoralis muscles has demonstrated a reduction in pain scores, spasticity and an increase in shoulder abduction and external rotation [28-30].  While supported by systematic reviews, heterogeneity in study design and outcome measures should be acknowledged when interpreting these results.

| Sign up to the ACNR email newsletter here |

Intra-articular corticosteroid injections also have a role in those patients when the clinical assessment suggests a focal musculoskeletal cause, for example in patients with a global reduced range of movement. The mechanism of action is predominantly through local reduction of inflammation. Glenohumeral intra-articular injections have both been demonstrated to reduce pain and increase function by improving range of motion in patients with focal HSP [31]. These injections are typically used in the context of adhesive capsulitis (or frozen shoulder) post-stroke. Subacromial corticosteroid intra-articular injections can be used if symptoms are due to impingement syndrome due to altered muscle biomechanics in the weak arm [32].

Hydrodistension is a procedure through which a high volume of a solution (commonly a combination of saline, corticosteroid and local anaesthetic) is injected into the joint with the aim of physically expanding the contracted capsule. Evidence in the context of HSP is promising in carefully selected cases [33]. The use of hydrodistension in hemiplegic shoulder pain is superior when compared with corticosteroid injection alone, with the literature demonstrating improvements in range of motion and function alongside reduced pain scores [33].

Outcome measures

Any clinical intervention should be evaluated for its effectiveness.  Valid outcome measures that are reliable and responsive should be used. To evaluate the effectiveness of our HSP management algorithm we propose a combination of measures spanning across the domains of the WHO International Classification of Functioning, Disability and Health (ICF) framework: body functions and structure outcomes (Visual Analogue Scale (VAS) pain, passive and active range of motion, Modified Ashworth Scale (MAS) for spasticity, MRC muscle power), activity-related outcomes (such as Arm Motor Ability Test) and participation and quality of life related outcomes (such as SF-36 or EQ5D) [34, 35].

Conclusion

A structured management protocol for HSP has been developed and proposed. It provides an approach to optimise the assessment and management of HSP in a stepwise manner according to the condition’s natural course and individual clinical presentation. Successful adoption of this algorithm requires multidisciplinary team, interdisciplinary working, training of relevant staff and availability of targeted therapeutic interventions. The proposed algorithm has the potential to improve pain symptoms, enhance functional recovery and improve quality of life for these individuals.

References

  1. Anwer S, Alghadir A. Incidence, prevalence, and risk factors of hemiplegic shoulder pain: a systematic review. International Journal of Environmental Research and Public Health. 2020 Jan;17(14):4962. https://doi.org/10.3390/ijerph17144962
  2. Poduri KR. Shoulder pain in stroke patients and its effects on rehabilitation. J Stroke Cerebrovasc Dis. 1993;3(4):261-6. doi: 10.1016/S1052-3057(10)80071-0. Epub 2010 Jun 8. PMID: 26487463.https://doi.org/10.1016/S1052-3057(10)80071-0
  3. Vasudevan JM, Browne BJ. Hemiplegic shoulder pain: an approach to diagnosis and management. Phys Med Rehabil Clin N Am. 2014 May;25(2):411-37. doi: 10.1016/j.pmr.2014.01.010. Epub 2014 Mar 14. PMID: 24787341. https://doi.org/10.1016/j.pmr.2014.01.010
  4. Turner-Stokes L, Jackson D. Shoulder pain after stroke: a review of the evidence base to inform the development of an integrated care pathway. Clinical rehabilitation. 2002 May;16(3):276-98. https://doi.org/10.1191/0269215502cr491oa
  5. Ada L, Foongchomcheay A, Canning C. Supportive devices for preventing and treating subluxation of the shoulder after stroke. Cochrane Database Syst Rev. 2005;2005(1):CD003863. Published 2005 Jan 25. https://doi.org/10.1002/14651858.CD003863.pub2
  6. Braus DF, Krauss JK, Strobel J. The shoulder-hand syndrome after stroke: a prospective clinical trial. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1994 Nov;36(5):728-33.https://doi.org/10.1002/ana.410360507
  7. Harrison RA, Field TS. Post stroke pain: identification, assessment, and therapy. Cerebrovasc Dis. 2015;39(3-4):190-201. https://doi.org/10.1159/000375397
  8. Krishna D Bharwani, MD, Maaike Dirckx, MD PhD, Frank JPM Huygen, MD PhD FIPP FFPMCAI (hon), Complex regional pain syndrome: diagnosis and treatment, BJA Education, Volume 17, Issue 8, August 2017, Pages 262-268, https://doi.org/10.1093/bjaed/mkx007
  9. Dromerick AW, Edwards DF, Kumar A. Hemiplegic shoulder pain syndrome: frequency and characteristics during inpatient stroke rehabilitation. Arch Phys Med Rehabil. 2008 Aug;89(8):1589-93. doi: 10.1016/j.apmr.2007.10.051. Epub 2008 Jul 2. PMID: 18597737. https://doi.org/10.1016/j.apmr.2007.10.051
  10. Terlemez R, Çiftçi S, Topaloglu M, Dogu B, Yilmaz F, Kuran B. Suprascapular nerve block in hemiplegic shoulder pain: comparison of the effectiveness of placebo, local anesthetic, and corticosteroid injections-a randomized controlled study. Neurol Sci. 2020 Nov;41(11):3243-3247. Epub 2020 May 10. PMID: 32388647. https://doi.org/10.1007/s10072-020-04362-0
  11. Hou Y, Wang Y, Sun X, Lou Y, Yu Y, Zhang T. Effectiveness of suprascapular nerve block in the treatment of hemiplegic shoulder pain: a systematic review and meta-analysis. Frontiers in neurology. 2021:1720.
    https://doi.org/10.3389/fneur.2021.723664
  12. Kuo CL, Hu GC. Post-stroke spasticity: a review of epidemiology, pathophysiology, and treatments. International Journal of Gerontology. 2018 Dec 1;12(4):280-4. https://doi.org/10.1016/j.ijge.2018.05.005
  13. Dromerick AW, Edwards DF, Kumar A. Hemiplegic shoulder pain syndrome: frequency and characteristics during inpatient stroke rehabilitation. Archives of physical medicine and rehabilitation. 2008 Aug 1;89(8):1589-93.
    https://doi.org/10.1016/j.apmr.2007.10.051
  14. Hansson P. Post‐stroke pain case study: clinical characteristics, therapeutic options and long‐term follow‐up. European journal of neurology. 2004 Apr;11:22-30 https://doi.org/10.1111/j.1471-0552.2004.00793.x
  15. Meyke R, Renzenbrink GJ, Buitenweg,JR, Van Dongen RT, Geurts AC, IJzerman MJ. Persistent shoulder pain in the first 6 months after stroke: results of a prospective cohort study. Arch Phys Med Rehabil. 2011 Jul;92(7):1139-45.
    https://doi.org/10.1016/j.apmr.2011.02.016
  16. Shepherd RB, Carr JH. The shoulder following stroke: preserving musculoskeletal integrity for function. Top Stroke Rehabil 1998; 4: 35-53. https://doi.org/10.1310/U7QR-A17D-16XR-5GBT
  17. Nadler M, Pauls MMH. Shoulder orthoses for the prevention and reduction of hemiplegic shoulder pain and subluxation: systematic review. Clin Rehabil. 2017 Apr;31(4):444-453. doi: 10.1177/0269215516648753. Epub 2016 Jul 10. https://doi.org/10.1177/0269215516648753
  18. Kumar P, Turton A , Cramp M, Smith M, McCabe C. Management of hemiplegic shoulder pain: A UK‐wide online survey of physiotherapy and occupational therapy practice. Physiotherapy research International. First published: 15 August 2020. https://doi.org/10.1002/pri.1874
  19. Ravichandran H , Janakiraman B , Sundaram S, Fisseha B, Gebreyesus T, Gelaw AY. Systematic Review on Effectiveness of shoulder taping in Hemiplegia.J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1463-1473. Epub 2019 Apr 5. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.03.021
  20. Blennerhassett JM, Gyngell K, Crean R. Reduced active control and passive range at the shoulder increase risk of shoulder pain during inpatient rehabilitation post-stroke: an observational study. J Physiother.2010;56(3):195-9. https://doi.org/10.1016/S1836-9553(10)70025-4
  21. Holmes RJ, & Connell LA. A survey of the current practice of intramuscular Botulinum toxin injections for hemiplegic shoulder pain in the UK. Perspectives in Rehabilitation. Pages 720-726 | Received 24 Jul 2017, Accepted 31 Oct 2017, Published online: 10 Nov 2017. https://doi.org/10.1080/09638288.2017.1400596
  22. Griffin C. Management of the hemiplegic shoulder complex. J topics stroke rehabil. 2014;21:316-318
    https://doi.org/10.1310/tsr2104-316
  23. Vafadar KA, Côté JN , Archambault PS. Effectiveness of functional electrical stimulation in improving clinical outcomes in the upper arm following stroke: a systematic review and meta-analysis . Biomed Res Int. 2015;2015:729768. Epub 2015 Jan 22. https://doi.org/10.1155/2015/729768
  24. WHO Reference: Ventafridda V, Saita L, Ripamonti C, De Conno F. WHO guidelines for the use of analgesics in cancer pain. International journal of tissue reactions. 1985 Jan 1;7(1):93-6.
  25. Kim JS, Bashford G, Murphy KT, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011 May;152(5):1018-1023. Epub 2011 Feb 12. PMID: 21316855. https://doi.org/10.1016/j.pain.2010.12.023
  26. Hesami O, Gharagozli K, Beladimoghadam N, Assarzadegan F, Mansouri B, Sistanizad M. The Efficacy of Gabapentin in Patients with Central Post-stroke Pain. Iran J Pharm Res. 2015 Winter;14(Suppl):95-101. PMID: 26185510; PMCID: PMC4499431.
  27. Kim JS. Pharmacological management of central post-stroke pain: a practical guide. CNS Drugs. 2014 Sep;28(9):787-97. PMID: 25112542. https://doi.org/10.1007/s40263-014-0194-y
  28. Francisco GE, McGuire JR. Poststroke spasticity management. Stroke. 2012 Nov;43(11):3132-6. doi: 10.1161/STROKEAHA.111.639831. Epub 2012 Sep 13. PMID: 22984012. https://doi.org/10.1161/STROKEAHA.111.639831
  29. Larrazet S, Joste R, Stefan A, Delaubier A, Gueyraud A, Foucault P, Guillou C, Dabbadie T. Hemiplegic shoulder pain: comparison of two sites of intramuscular injections of botulinum toxin type A,”epautox” study. Annals of Physical and Rehabilitation Medicine. 2016 Sep 1;59:e72.
    https://doi.org/10.1016/j.rehab.2016.07.167
  30. Xie HM, Guo TT, Sun X, Ge HX, Chen XD, Zhao KJ, Zhang LN. Effectiveness of Botulinum Toxin A in Treatment of Hemiplegic Shoulder Pain: A Systematic Review and Meta-Analysis. Archives of Physical Medicine and Rehabilitation. 2021 Jan 14. https://doi.org/10.1016/j.apmr.2020.12.010
  31. Tubay A, Bal S, Bayram KB, Kocyigit H, Gurgan A. Suprascapular nerve block and glenohumeral injection in hemiplegic shoulder pain: to compare the effectiveness on pain and disability/Hemiplejik agrili omuzda supraskapular sinir blokaji ve glenohumeral eklem enjeksiyonu: agri ve ozurluluk uzerindeki etkilerinin karsilastirilmasi. Turkish Journal of Physical Medicine and Rehabilitation. 2012 Dec 1;58(4):299-307.
    https://doi.org/10.4274/tftr.54771
  32. Rah UW, Yoon SH, Moon DJ, Kwack KS, Hong JY, Lim YC, Joen B. Subacromial corticosteroid injection on poststroke hemiplegic shoulder pain: a randomized, triple-blind, placebo-controlled trial. Archives of physical medicine and rehabilitation. 2012 Jun 1;93(6):949-56.
    https://doi.org/10.1016/j.apmr.2012.02.002
  33. Dogan A, Demirtas R, Ozgirgin N. Intraarticular hydraulic distension with steroids in the management of hemiplegic shoulder. Turkish Journal of Medical Sciences. 2013 Apr 2;43(2):304-10. https://doi.org/10.3906/sag-1110-22
  34. Schepers VP, Ketelaar M, Van de Port IG, Visser-Meily JM, Lindeman E. Comparing contents of functional outcome measures in stroke rehabilitation using the International Classification of Functioning, Disability and Health. Disability and rehabilitation. 2007 Jan 1;29(3):221-30. https://doi.org/10.1080/09638280600756257
  35. Sivan M, O’Connor RJ, Makower S, Levesley M, Bhakta B. Systematic review of outcome measures used in the evaluation of robot-assisted upper limb exercise in stroke. Journal of rehabilitation medicine. 2011 Feb 1;43(3):181-9. https://doi.org/10.2340/16501977-0674

Related

  • Published by Whitehouse Publishing
  • The Lynch, Mere, Wiltshire BA12 6DQ, United Kingdom
  • info@acnr.co.uk
  • +44 1747 860168

FOLLOW US

  • Facebook
  • Instagram
  • X
  • Linkedin

RSS FEEDS

  • ACNR RSS
  • All
  • Articles
  • Events

ACNR SIGNUPS

Join our email list to be notified when there is new content or upcoming events.

© 2026 ACNR. Published by Whitehouse Publishing. Read our Privacy and Cookie Policy. Website by Sugar Web.

SIGN UP FOR OUR EMAILING LIST

Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.

For UK-based specialists, sign up for our journal mailing list.

WARNING

URL here

You are now leaving the ACNR website, please click the "Continue" button below. If you do not wish to leave, please close this pop-up.

Continue